Medtronic plc (2M6.DE)
EUR 77.58
(-0.12%)
EUR 77.58
(-0.12%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 32.36 Billion | 31.22 Billion | 31.68 Billion | 30.11 Billion | 28.91 Billion | 30.55 Billion |
| Cost of Revenue | 11.21 Billion | 10.71 Billion | 10.14 Billion | 10.48 Billion | 9.42 Billion | 9.15 Billion |
| Gross Profit | 21.14 Billion | 20.5 Billion | 21.54 Billion | 19.63 Billion | 19.48 Billion | 21.4 Billion |
| Operating Expenses | 15.62 Billion | 14.67 Billion | 15.63 Billion | 14.73 Billion | 14.26 Billion | 14.77 Billion |
| Selling, General and Administrative Expenses | 10.73 Billion | 10.41 Billion | 10.29 Billion | 10.14 Billion | 10.1 Billion | 10.41 Billion |
| Research and Development Expenses | 2.73 Billion | 2.69 Billion | 2.74 Billion | 2.49 Billion | 2.33 Billion | 2.33 Billion |
| Other Expenses | 2.53 Billion | 515 Million | 318 Million | 336 Million | 356 Million | 373 Million |
| Cost and Expenses | 26.84 Billion | 25.39 Billion | 25.77 Billion | 25.22 Billion | 23.69 Billion | 23.92 Billion |
| Operating Income | 5.14 Billion | 5.48 Billion | 5.75 Billion | 4.48 Billion | 4.79 Billion | 6.26 Billion |
| Interest Expense | 719 Million | 636 Million | 553 Million | 925 Million | 1.09 Billion | 1.44 Billion |
| Income Tax Expense | 1.13 Billion | 1.58 Billion | 456 Million | 265 Million | -751 Million | 547 Million |
| Earnings before Tax | 4.83 Billion | 5.36 Billion | 5.51 Billion | 3.89 Billion | 4.05 Billion | 5.19 Billion |
| Net Income | 3.67 Billion | 3.75 Billion | 5.03 Billion | 3.6 Billion | 4.78 Billion | 4.63 Billion |
| Earnings Per Share Basic | 2.76 | 2.83 | 3.75 | 2.68 | 3.57 | 3.44 |
| Earnings Per Share Diluted | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 | 3.41 |
| Weighted Average Shares Outstanding | 1.33 Billion | 1.32 Billion | 1.34 Billion | 1.34 Billion | 1.34 Billion | 1.34 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.33 Billion | 1.33 Billion | 1.35 Billion | 1.35 Billion | 1.35 Billion | 1.35 Billion |
| Gross Margin | 0.65 | 0.66 | 0.68 | 0.65 | 0.67 | 0.70 |
| EBIT Margin | 0.25 | 0.29 | 0.28 | 0.26 | 0.29 | 0.32 |
| Profit Margin | 0.11 | 0.12 | 0.16 | 0.12 | 0.17 | 0.15 |
| EBITDA | 8.2 Billion | 8.69 Billion | 8.77 Billion | 7.52 Billion | 7.81 Billion | 9.3 Billion |
| Earnings Before Tax Margin | 0.16 | 0.18 | 0.18 | 0.15 | 0.17 | 0.21 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 7.91 Billion | 32.36 Billion | 8.58 Billion | 8.08 Billion | 7.98 Billion | 7.7 Billion |
| Cost of Revenue | 2.76 Billion | 11.21 Billion | 3.04 Billion | 2.78 Billion | 2.76 Billion | 2.62 Billion |
| Gross Profit | 5.15 Billion | 21.14 Billion | 5.54 Billion | 5.3 Billion | 5.22 Billion | 5.07 Billion |
| Operating Expenses | 3.74 Billion | 15.62 Billion | 4.33 Billion | 3.8 Billion | 3.77 Billion | 3.71 Billion |
| Selling, General and Administrative Expenses | 2.65 Billion | - | 2.76 Billion | 2.67 Billion | 2.68 Billion | 2.61 Billion |
| Research and Development Expenses | 676 Million | - | 675 Million | 695 Million | 698 Million | 668 Million |
| Other Expenses | 157 Million | 412 Million | 5 Million | 177 Million | 154 Million | 76 Million |
| Cost and Expenses | 6.5 Billion | 26.84 Billion | 7.38 Billion | 6.58 Billion | 6.53 Billion | 6.33 Billion |
| Operating Income | 1.27 Billion | 5.14 Billion | 1.05 Billion | 1.48 Billion | 1.34 Billion | 1.26 Billion |
| Interest Expense | 167 Million | 719 Million | 202 Million | 188 Million | 180 Million | 148 Million |
| Income Tax Expense | 220 Million | 1.13 Billion | 197 Million | 135 Million | 402 Million | 400 Million |
| Earnings before Tax | 1.26 Billion | 4.83 Billion | 855 Million | 1.47 Billion | 1.31 Billion | 1.19 Billion |
| Net Income | 1.04 Billion | 3.67 Billion | 654 Million | 1.32 Billion | 909 Million | 791 Million |
| Earnings Per Share Basic | 0.74 | - | 0.49 | 0.99 | 0.68 | 0.59 |
| Earnings Per Share Diluted | 0.74 | - | 0.49 | 0.99 | 0.68 | 0.59 |
| Weighted Average Shares Outstanding | 1.29 Billion | 1.32 Billion | 1.33 Billion | 1.32 Billion | 1.33 Billion | 1.33 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.33 Billion | 1.32 Billion | 1.33 Billion | 1.33 Billion | 1.33 Billion |
| Gross Margin | 0.65 | 0.65 | 0.65 | 0.66 | 0.65 | 0.66 |
| EBIT Margin | 0.28 | - | 0.22 | 0.29 | 0.28 | 0.27 |
| Profit Margin | 0.13 | 0.11 | 0.08 | 0.16 | 0.11 | 0.10 |
| EBITDA | 2.22 Billion | - | 1.86 Billion | 2.32 Billion | 2.27 Billion | 2.11 Billion |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.12 | 0.18 | 0.17 | 0.16 |
BLS
2PP
SUZLON
002162
CNH
300451